Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study
Authors:
- J. R. MontgomeryJMJ. R. Montgomery
- K. J. Van ArendonkK. J. Van Arendonk
- M D StegallMSM D Stegall
- T. B. DunnTDT. B. Dunn
Open Access
- 9 June 2014
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 14 (7) , 1573-1580
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01DK098431)
This publication has 36 references indexed in Scilit:
- Interpretation of HLA single antigen bead assaysTransplantation Reviews, 2013
- Rates of False Flagging Due to Statistical Artifact in CMS Evaluations of Transplant Programs: Results of a Stochastic SimulationAmerican Journal of Transplantation, 2013
- Five-Year Outcomes in Living Donor Kidney Transplants With a Positive CrossmatchAmerican Journal of Transplantation, 2012
- HLA Antibody Detection and Characterization by Solid Phase Immunoassays: Methods and Pitfalls2012
- Incompatible Live-Donor Kidney Transplantation in the United StatesClinical Journal of the American Society of Nephrology, 2011
- Desensitization in HLA-Incompatible Kidney Recipients and SurvivalNew England Journal of Medicine, 2011
- Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney TransplantationAmerican Journal of Transplantation, 2010
- Positive Cross-Match Living Donor Kidney Transplantation: Longer-Term OutcomesAmerican Journal of Transplantation, 2009
- Transplant data: sources, collection and research considerations, 2004American Journal of Transplantation, 2005
- Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patientsTransplantation, 2003